CLINICAL_TRIALS
ClinicalTrials.gov record update
Peripheral Blood Stem Cell Allotransplantation For Hematological Malignancies Using Ex Vivo CD34 Selection - a Platform For Adoptive Cellular Therapies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01866839
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:38.526442+00:00
- Published At
- 2020-05-26T00:00:00+00:00
- Record Updated At
- 2020-07-21
- Results Posted At
- 2020-05-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["MDS (Myelodysplastic Syndrome)", "Myeloproliferative Disorder", "Lymphoma, Non-Hodgkin", "ALL (Acute B-Lymphoblastic Leukemia)", "AML (Acute Myelogenous Leukemia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-07-21"- protocolSection.identificationModule.nctId
"NCT01866839"- protocolSection.identificationModule.officialTitle
"Peripheral Blood Stem Cell Allotransplantation For Hematological Malignancies Using Ex Vivo CD34 Selection - a Platform For Adoptive Cellular Therapies"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-05-26"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.